You are here: Industry Insights > CureVac

News List

CureVac, Celonic Enter COVID-19 Vax Mfg. Pact contractpharma
March 31, 2021
Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.
CureVac Expands Late-stage Trials of COVID Vax Candidate contractpharma
March 23, 2021
CureVac N.V. plans to expand and further specify the protocols of its ongoing late-stage clinical trials with its COVID-19 vaccine candidate, CVnCoV.
CureVac, Novartis Ink COVID Vax Mfg. Pact contractpharma
March 05, 2021
Novartis to manufacture the mRNA and bulk drug product of the CVnCoV vaccine for up to 50 million doses by the end of 2021.
CureVac’s COVID-19 vaccine begins rolling review with EMA pharmatimes
February 19, 2021
German biopharmaceutical company CureVac has announced the initiation of a rolling review with the European Medicines Agency (EMA) for its mRNA-based COVID-19 vaccine, CVnCoV.
CureVac & Rentschler Biopharma Collaborate on Vaccine contractpharma
February 09, 2021
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for ...
CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants contractpharma
February 07, 2021
Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.
GSK, CureVac Enter New €150M COVID Vax Pact contractpharma
February 04, 2021
GSK will support the manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine candidate CVnCoV in 2021.
Bayer to manufacture mRNA vaccine in Germany worldpharmanews
February 02, 2021
In a joint press briefing yesterday together with German Health Minister Jens Spahn, Minister-President of North Rhine-Westphalia, Armin Laschet, and Chief Executive Officer of CureVac N.V., Franz-Werner Haas, Member of the Board of Management ...
CureVac, Rentschler Ramp up COVID Vax Production contractpharma
February 02, 2021
CureVac N.V. and Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, initiated the set-up of manufacturing capabilities for CureVac´s COVID-19 vaccine, CVnCoV.
Bayer examining if it can help CureVac with COVID-19 vaccine production: CEO expresspharma
January 18, 2021
CureVac's COVID-19 vaccine candidate is in late-stage clinical trials and has not yet been approved.

Previous page 1 2 3 4 5 Next page